The use of LCMV-specific T cell hybridomas for the quantitative analysis of MHC class I restricted antigen presentation

被引:9
作者
Schwarz, K
van den Broek, M
de Giuli, R
Seelentag, WW
Shastri, N
Groettrup, M
机构
[1] Cantonal Hosp St Gall, Res Dept, CH-9007 St Gallen, Switzerland
[2] Univ Zurich Hosp, Dept Pathol, Inst Expt Immunol, CH-8091 Zurich, Switzerland
[3] Cantonal Hosp St Gall, Clin Radiooncol, CH-9007 St Gallen, Switzerland
[4] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA
关键词
LCMV; cytotoxic T lymphocyte; hybridoma; proteasome; antigen presentation;
D O I
10.1016/S0022-1759(99)00236-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:199 / 202
页数:4
相关论文
共 4 条
[1]  
Gallimore A, 1998, J EXP MED, V187, P1647
[2]   The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope [J].
Gallimore, A ;
Schwarz, K ;
van den Broek, M ;
Hengartner, H ;
Groettrup, M .
MOLECULAR IMMUNOLOGY, 1998, 35 (10) :581-591
[3]   LACZ INDUCIBLE, ANTIGEN MHC-SPECIFIC T-CELL HYBRIDS [J].
SANDERSON, S ;
SHASTRI, N .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (03) :369-376
[4]  
SHASTRI N, 1993, J IMMUNOL, V150, P2724